What is the initial dose of Lantus (insulin glargine) for a patient weighing 155 pounds?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Lantus Dosing for a 155-pound Patient

For a patient weighing 155 pounds (70.3 kg), the recommended starting dose of Lantus (insulin glargine) is 0.1-0.2 units/kg/day, which equals approximately 7-14 units once daily. 1, 2

Dosing Calculation

  • The FDA-approved starting dose for insulin-naive type 2 diabetes patients is 0.2 units/kg or up to 10 units once daily 2
  • For a 155-pound (70.3 kg) patient:
    • At 0.1 units/kg: 7 units
    • At 0.2 units/kg: 14 units
    • The American Diabetes Association recommends starting with 10 units per day or 0.1-0.2 units/kg/day 3

Administration Guidelines

  • Administer Lantus subcutaneously once daily at any time of day, but at the same time every day 2
  • Inject into the abdominal area, thigh, or deltoid, and rotate injection sites within the same region to reduce the risk of lipodystrophy 2
  • For type 2 diabetes, Lantus is usually prescribed in conjunction with metformin and sometimes one additional non-insulin agent 3

Dose Titration

  • Increase the dose by 2-4 units every 3-4 days until fasting blood glucose reaches target range (80-130 mg/dL) 1
  • If fasting glucose is ≥180 mg/dL, consider increasing the dose by 4 units 1
  • Equipping patients with an algorithm for self-titration of insulin doses based on self-monitoring of blood glucose improves glycemic control 3

Important Considerations

  • For type 1 diabetes patients, Lantus must be used concomitantly with short-acting insulin 2
  • Lantus provides basal insulin coverage but does not treat postprandial hyperglycemia; supplemental short-acting insulin at mealtimes may be needed 4
  • During changes to insulin regimen, increase the frequency of blood glucose monitoring 2
  • In obese, insulin-resistant patients, it may be better to administer insulin glargine in two separate doses due to high volumes of injected insulin required 4

Common Pitfalls to Avoid

  • Delaying insulin therapy in patients not achieving glycemic goals can be harmful 1
  • Not adjusting doses based on self-monitoring of blood glucose levels can lead to poor glycemic control 1
  • Overbasalization (using higher than necessary basal insulin doses) can mask insufficient mealtime insulin coverage 1
  • Failure to recognize that insulin requirements may change with weight changes, illness, or changes in physical activity 1

By starting with 10 units daily (or 0.1-0.2 units/kg/day) and carefully titrating the dose based on blood glucose monitoring, most patients can achieve optimal glycemic control while minimizing the risk of hypoglycemia.

References

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Insulin Glargine: a review 8 years after its introduction.

Expert opinion on pharmacotherapy, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.